CONNECTING Healthcare EXPERTISE

THE CLINICIAN EXCHANGE is a virtual exchange designed to pair specific clinical skillsets with specific industry initiatives.

EXCHANGE YOUR EXPERTISE

Learn how you can unlock the power of your expertise and experience to impact the healthcare industry in ways never before imagined

REGISTER NOWLEARN MORE

EXTEND, EXCEL…EXPLORE THE EXCHANGE

Learn how you can cost-effectively multiply your sales, education and R&D resources in an instant

REGISTER NOWLEARN MORE

COMMUNITY PORTAL

IN THE NEWS

CLINICIAN NEWS

Provided by: Medscape

Is it Fat or Lean That Ultimately Determines AF Risk?

Published: Mon, 26 Jun 2017 12:00:00 EDT
A new study suggests that lean body mass is the predominant anthropometric risk factor for atrial fibrillation, but the relationship may not be so black-and-white, according to this commentary.
Journal of the American College of Cardiology

An Unusually Large Carbuncle of the Temporofacial Region

Published: Mon, 26 Jun 2017 12:00:00 EDT
How was this extensive carbuncle over the temporofacial region effectively managed?
Wounds

Management of the Diabetic Patient Needing Emergency Surgery

Published: Mon, 26 Jun 2017 12:00:00 EDT
The emergency surgical patient with diabetes presents unique challenges, and is often considered high risk. What can be done to improve outcomes for these patients?
BJA Education
Displaying results 16-18 (of 20)
 1 - 2 - 3 - 4 - 5 - 6 - 7 

HEALTHCARE SUPPLIER NEWS

Cash-strapped ImmunoCellular halts brain cancer vaccine trial, eyes 'strategic alternatives'

Published: Wed, 21 Jun 2017 11:34:31 +0000
ImmunoCellular Therapeutics has been forced to suspend a phase 3 trial of its lead cancer vaccine, ICT-107, after failing to raise the funds it needs to complete the study.

Gottlieb’s FDA to rethink targeted therapy regulation to speed development, drive down healthcare costs

Published: Wed, 21 Jun 2017 10:25:42 +0000
The FDA is working on a medical innovation development plan designed to lower healthcare costs by streamlining the path to market for targeted therapies and other novel drugs. Commissioner Scott Gottlieb, M.D., pitched the plan as a broad drive to ensure the FDA has the tools and policies to encourage and evaluate innovative therapies.

Apple Tree helps Big Apple biotech Syntimmune in $50M series B

Published: Wed, 21 Jun 2017 08:19:40 +0000
New York biotech Syntimmune has got off a beefy $50 million series B round as it looks to use the funds for its FcRn biology tests.
Displaying results 16-18 (of 25)
 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 

HAVE A QUESTION?

Clinician Owned and Veteran Owned

copyright 2017 THE CLINICIAN EXCHANGE. Privacy Policy
Top